Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Arcadian Capital LLC v. Cura Partners Inc., et al
Case Number:
2:20-cv-03372
Court:
Nature of Suit:
Judge:
Firms
-
June 30, 2021
Cura Partners Settles Claims With Consultant Over Merger
Cannabis company Cura Partners and an investing consultant have reached an agreement to settle the consultant's suit over an unpaid finder's fee stemming from Cura Partners' acquisition in a $950 million deal, according to a California federal court filing.
-
March 08, 2021
Consultant Says Cura Partners Can't Escape Finder's Fee Suit
Investing consultant Arcadian Capital LLC is pushing back on cannabis company Cura Partners' bid to toss Arcadian's suit over an unpaid finder's fee stemming from Cura Partners' acquisition in a $950 million deal, saying the company intended to defraud Arcadian "from day one."
-
March 01, 2021
Cura Partners Seeks Early Win In Consulting Fee Fight
Cannabis company Cura Partners has asked a federal judge for summary judgment in a suit brought by investing consultant Arcadian Capital LLC over Curaleaf's $950 million acquisition of Cura Partners, arguing that the consulting agreement is unlawful and unenforceable.
-
February 05, 2021
Consultant, Cura Partners Trade Sanction Bids In Merger Fight
An investing consultant that claims to have made the introduction that led to pot company Curaleaf's $950 million acquisition of Cura Partners is locked in a battle of sanctions with Cura Partners, with both sides accusing the other of evasive and improper tactics during discovery.